ArticleESMO open2026

DOSET: dose optimization with simultaneous efficacy and toxicity evaluation, motivated by a first-in-human phase I CAR T lymphoma trial.

X Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.